Home > Press Releases

Press Releases (Page 19)

Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2021 and Announces Two Additional Acquisitions

BANNOCKBURN, Ill., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2021. The Company also announced that it acquired Wasatch Infusion LLC ("Wasatch"), an infusion center operator... ❯❯❯

Vancouver discovery will make ‘Magic Mushroom’ mental health care cheaper

Breakthrough process designed by Vancouver scientists uses bacteria as factories to make Psilocybin for psychedelic assisted therapies to treat depression, addictions and PTSD.Vancouver, BC, Feb. 23, 2022 (GLOBE NEWSWIRE) -- A team of Vancouver scientists has discovered a new process to cost-effectively make psilocybin, the active ingredient in magic mushrooms, paving the way for greater and more affordable treatments for a range of... ❯❯❯

RadNet, Inc. Announces Date of its Fourth Quarter 2021 Financial Results Conference Call

LOS ANGELES, Feb. 23, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its fourth quarter 2021 financial results on Tuesday, March 1st, 2022 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). Investors are... ❯❯❯

Core One Labs’ Files Milestone Patent for Protection of its Recombinant Production System for Optimized Biosynthetic N-methyltryptamine (NMT)

VANCOUVER, British Columbia, Feb. 21, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (“Core One” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Vocan Biotechnologies Inc. of Victoria, British Columbia, has filed a patent application with the United States Patent and Trademark Office (“USPTO”) for the production of biosynthetic... ❯❯❯

Allarity Therapeutics Receives Refusal to File Letters from U.S. FDA

Refusal to File letters concern the new drug application for dovitinib and the DRP®-Dovitinib companion diagnostic pre-market approval applicationAllarity intends to seek guidance from the FDA on how to further advance dovitinib and its accompanying DRP®-Dovitinib companion diagnostic towards approval Press releaseCambridge, MA U.S.A. (February 18, 2022) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”), a... ❯❯❯

Treatment’s Doctor-Built Digital Health App now on Google Play Store

VANCOUVER, British Columbia, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. After a successful launch on the Apple App Store, Treatment’s revolutionary symptom assessment... ❯❯❯

Shineco, Inc. Announces Strategic Alliance to Enhance the Research and Development of Innovative Drugs and Medical Devices

BEIJING, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that on February 16, 2022, the Company entered into a strategic cooperation framework agreement (the “Agreement”) with Beijing Jinshengyun Pharmaceutical Technology Co., Ltd. (“JSY”), a Beijing-based... ❯❯❯

Press release Biocartis Group NV: BIOCARTIS ANNOUNCES 2021 FULL YEAR RESULTS ON 24 FEBRUARY 2022

PRESS RELEASE: REGULATED INFORMATION 17 February 2022, 07:00 CET BIOCARTIS ANNOUNCES 2021 FULL YEAR RESULTS ON 24 FEBRUARY 2022 Mechelen, Belgium, 17 February 2022 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), announces today that it will report its 2021 full year results and 2022 outlook on 24 February 2022 at 07:00 CET. The Biocartis... ❯❯❯

LifeLabs’ President and CEO named one of the “Top 25 Biotech CEOs” for the second consecutive year

Toronto, Ontario, Feb. 16, 2022 (GLOBE NEWSWIRE) -- We are pleased to share that LifeLabs’ President and CEO, Charles Brown, has been named one of the “Top 25 Biotech CEOs of 2022” by The Healthcare Technology Report. This is Charles’ second consecutive year for receiving this recognition. Hundreds of nominations were submitted this year to The Healthcare Technology Report and winners were selected based on leaders’... ❯❯❯

Sienna Announces February Dividend

MARKHAM, Ontario, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of February 2022, representing $0.936 per Common Share on an annualized basis. The dividend will be payable on March 15, 2022 to shareholders of record as at February 28, 2022.   The Company's... ❯❯❯